Quick Answer
Bolt Biotherapeutics, Inc. reported Total Assets of $56.75 million for fiscal year 2025.
Bolt Biotherapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $56.75M | -43.0% |
| 2024 | $99.63M | -37.6% |
| 2023 | $159.78M | -29.9% |
| 2022 | $227.81M | -26.0% |
| 2021 | $307.72M | +561.2% |
| 2020 | $46.54M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $65.05M | -40.5% | -13.8% |
| June 30, 2025 | $75.50M | -39.2% | -12.1% |
| March 31, 2025 | $85.86M | -39.9% | -13.8% |
| December 31, 2024 | $99.63M | -37.6% | -8.9% |
| September 30, 2024 | $109.33M | -37.6% | -12.0% |
| June 30, 2024 | $124.18M | -34.9% | -13.1% |
| March 31, 2024 | $142.89M | -30.7% | -10.6% |
| December 31, 2023 | $159.78M | -29.9% | -8.9% |
- Bolt Biotherapeutics, Inc. showed a decrease of -43.0% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Bolt Biotherapeutics, Inc.’s total assets has grown by 21.9% (from $46.54 million to $56.75 million).
- The most recent figure is from Bolt Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: